840(top 1%)
papers
41.7K(top 0.1%)
citations
104(top 0.1%)
h-index
168(top 0.1%)
g-index
917
all documents
44.2K
doc citations
3.6K
citing journals

Top Articles

#TitleJournalYearCitations
1FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0European Journal of Nuclear Medicine and Molecular Imaging20101,147
2Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical ProstatectomyJournal of Nuclear Medicine2015907
3Diagnostic Efficacy of 68 Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate CancerJournal of Urology2016659
4Distraction modulates connectivity of the cingulo-frontal cortex and the midbrain during pain—an fMRI analysisPain2004592
5Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up studyEuropean Journal of Nuclear Medicine and Molecular Imaging2003510
6Prevalence of Amyloid PET Positivity in Dementia SyndromesJAMA - Journal of the American Medical Association2015501
7Current use of PSMA–PET in prostate cancer managementNature Reviews Urology2016469
8First Clinical Experience with Integrated Whole-Body PET/MR: Comparison to PET/CT in Patients with Oncologic DiagnosesJournal of Nuclear Medicine2012466
9Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate CancerEuropean Urology2016456
10Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Carcinoma and Response to TreatmentJournal of Clinical Oncology2004448
11Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomographyCancer Research2001446
1268Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human StudiesJournal of Nuclear Medicine2015432
13Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal studyLancet Neurology, The2018383
14The detection rate of [11C]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancerEuropean Journal of Nuclear Medicine and Molecular Imaging2008355
15O -(2-[ 18 F]Fluoroethyl)- l -tyrosine and l -[methyl- 11 C]methionine uptake in brain tumours: initial results of a comparative studyEuropean Journal of Nuclear Medicine and Molecular Imaging2000353
16Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapyInternational Journal of Radiation Oncology Biology Physics2005351
17Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysisJournal of Nuclear Medicine2001351
18Positron Emission Tomography Using [18F]Galacto-RGD Identifies the Level of Integrin αvβ3 Expression in ManClinical Cancer Research2006337
19Exploring the Role of RGD-Recognizing Integrins in CancerCancers2017308
20Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancerEuropean Journal of Nuclear Medicine and Molecular Imaging2016302
21[18F]Galacto-RGD:  Synthesis, Radiolabeling, Metabolic Stability, and Radiation Dose EstimatesBioconjugate Chemistry2004299
22FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findingsEuropean Journal of Nuclear Medicine and Molecular Imaging2003290
23SPECT/CTJournal of Nuclear Medicine2008280
24Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targetingJournal of Nuclear Medicine1999265
25Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical ProstatectomyJournal of Nuclear Medicine2019238
26Hypoxia Imaging With FAZA-PET and Theoretical Considerations With Regard to Dose Painting for Individualization of Radiotherapy in Patients With Head and Neck CancerInternational Journal of Radiation Oncology Biology Physics2007226
2768Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy PlanningJournal of Nuclear Medicine2018226
28Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose.Journal of Clinical Oncology1996223
29An Interindividual Comparison of O-(2- [18F]Fluoroethyl)-L-Tyrosine (FET)– and L-[Methyl-11C]Methionine (MET)–PET in Patients With Brain Gliomas and MetastasesInternational Journal of Radiation Oncology Biology Physics2011222
30[18F]Galacto-RGD Positron Emission Tomography for Imaging of αvβ3 Expression on the Neovasculature in Patients with Squamous Cell Carcinoma of the Head and NeckClinical Cancer Research2007217
31Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage LymphadenectomyJournal of Nuclear Medicine2016213
32Imaging of integrin αvβ3 expressionCancer and Metastasis Reviews2008208
33Treatment Outcome, Toxicity, and Predictive Factors for Radioligand Therapy with 177Lu-PSMA-I&T in Metastatic Castration-resistant Prostate CancerEuropean Urology2019206
34Assessment of Axillary Lymph Node Involvement in Breast Cancer Patients With Positron Emission Tomography Using Radiolabeled 2-(Fluorine-18)-fluoro-2-deoxy-D-glucoseJournal of the National Cancer Institute1996205
35Radiolabelled RGD peptides for imaging and therapyEuropean Journal of Nuclear Medicine and Molecular Imaging2012203
36Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patientsJournal of Nuclear Medicine2005202
37Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET studyNeurobiology of Aging2004201
38PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18 F-labelled, carbohydrated analogue of octreotideEuropean Journal of Nuclear Medicine and Molecular Imaging2003197
3999mTechnetium-based Prostate-specific Membrane Antigen–radioguided Surgery in Recurrent Prostate CancerEuropean Urology2019195
40Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-studyNeurobiology of Aging2007194
41Prostate-specific Membrane Antigen–radioguided Surgery for Metastatic Lymph Nodes in Prostate CancerEuropean Urology2015192
42E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PETEuropean Journal of Nuclear Medicine and Molecular Imaging2021188
43In vivo molecular imaging of chemokine receptor CXCR 4 expression in patients with advanced multiple myelomaEMBO Molecular Medicine2015180
44The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate CancerEuropean Urology2011177
45MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patientsEuropean Radiology2008176
46Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomasJournal of Nuclear Medicine1995176
47Comparison of Integrin αvβ3 Expression and Glucose Metabolism in Primary and Metastatic Lesions in Cancer Patients: A PET Study Using 18F-Galacto-RGD and 18F-FDGJournal of Nuclear Medicine2008173
48CXCR4 Expression Increases Liver and Lung Metastasis in a Mouse Model of Pancreatic CancerGastroenterology2005172
49Future of Theranostics: An Outlook on Precision Oncology in Nuclear MedicineJournal of Nuclear Medicine2019172
50An SPM8-Based Approach for Attenuation Correction Combining Segmentation and Nonrigid Template Formation: Application to Simultaneous PET/MR Brain ImagingJournal of Nuclear Medicine2014171